Phase II trial of imatinib mesylate and hydroxyurea for grade III malignant gliomas
Year: 2006
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Duke Medical Center
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W19038098
